Ben is a vascular biologist, tissue engineer and regenerative medicine scientist by training. He has spent the past 15 years in industry leading successful R&D teams and business development efforts focused on developing complex 3D human tissue systems. Prior to co-founding Trestle, Ben served as VP of Research & Preclinical Development at Organovo, where he oversaw preclinical translational research, and was responsible for management and oversight of Organovo’s external academic collaborations and helped guide and develop Organovo’s IP estate. He also led initial R&D efforts focused on use of 3D bioprinting for creation of in vitro tissue models for use in drug discovery, ADME/Tox, and disease modeling. Ben is an author on more than 20 scientific articles and book chapters, and a named inventor on more than 10 patents. Ben received his B.S. in Zoology from the University of Washington, a Ph.D. from the University of Arizona in Physiological Sciences, and conducted postdoctoral training at the Yale School of Medicine in the laboratory of Jordan Pober M.D., Ph.D.